Upstream Bio, Inc. (UPB) completed its IPO back in October 2024, raising approximately $293 million. This biotech is placing itself in a good position to do well because it is leveraging an entirely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback